Clinical Trials in Saint-Mandé, France
26 recruiting
Showing 1–20 of 30 trials
Recruiting
Phase 3
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris1,210 enrolled30 locationsNCT03819101
Recruiting
PRostate Olaparib Real World Evidence Study
Metastatic Castration-resistant Prostate Cancer
AstraZeneca300 enrolled65 locationsNCT06031805
Recruiting
Phase 3
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Gilead Sciences695 enrolled205 locationsNCT06801834
Recruiting
Phase 3
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
Prostate Cancer Metastatic
UNICANCER300 enrolled95 locationsNCT04916613
Recruiting
Phase 1Phase 2
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
Advanced Solid Tumors
Regeneron Pharmaceuticals933 enrolled57 locationsNCT04626635
Recruiting
Not Applicable
Same Day Ambulatory Appendectomy (SAMBA)
Appendicitis
Centre Hospitalier Universitaire de Nice1,400 enrolled33 locationsNCT05691348
Recruiting
Phase 1Phase 2
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Metastatic Solid TumorsLocally Advanced Solid Tumors
Turning Point Therapeutics, Inc.500 enrolled165 locationsNCT03093116
Recruiting
Not Applicable
Radiofrequency Ablation vs Doppler-guided Haemorrhoidal Artery Ligation in the Treatment of Haemorrhoidal Disease
HaemorrhoidsInternal HaemorrhoidsGrade II/III Haemorrhoids
Centre Hospitalier Departemental Vendee168 enrolled18 locationsNCT06170736
Recruiting
Phase 3
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
Metastatic Castration-resistant Prostate Cancer
Amgen675 enrolled164 locationsNCT06691984
Recruiting
Phase 2
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
Metastatic CancerAdvanced CancerMalignant Neoplasm of Lung
Mirati Therapeutics Inc.200 enrolled120 locationsNCT05853575
Recruiting
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
Alopecia AreataHidradenitis SuppurativaNon-Segmental Vitiligo (NSV)
AbbVie2,795 enrolled116 locationsNCT07136467
Recruiting
Phase 3
Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Metastatic Oesogastric Adenocarcinoma
Federation Francophone de Cancerologie Digestive324 enrolled64 locationsNCT07270991
Recruiting
Prognostic Determinants in Patients With Diabetic Foot Ulcer.
Diabetic Foot Ulcer
University Hospital, Bordeaux1,000 enrolled26 locationsNCT04533152
Recruiting
Not Applicable
68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)
Triple-Negative Breast Cancer
Institut Curie60 enrolled6 locationsNCT06349512
Recruiting
Not Applicable
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
Metastatic Colorectal CancerBRAF V600E Mutation Positive
UNICANCER400 enrolled45 locationsNCT05639413
Recruiting
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Atopic DermatitisEczema
Pfizer183 enrolled30 locationsNCT05689151
Recruiting
Phase 2
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy
Urothelial Bladder Cancer
Institut Claudius Regaud130 enrolled20 locationsNCT04428554
Recruiting
Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Cancer
Bayer402 enrolled383 locationsNCT04464226
Recruiting
Phase 2
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
Gastric Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group120 enrolled37 locationsNCT06253611
Recruiting
Not Applicable
Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
Metastatic Triple-Negative Breast Carcinoma
UNICANCER472 enrolled51 locationsNCT06505018